Skip to main content
. Author manuscript; available in PMC: 2011 Dec 15.
Published in final edited form as: Arch Neurol. 2011 Nov;68(11):1447–1453. doi: 10.1001/archneurol.2011.245

Table 4.

Outcome Measures and fMRI Task Performance Dataa

Variable Mean (SD)
F Value P Value
Chemotherapy (n=25) No Chemotherapy (n=19) Healthy Control Individuals (n=18)
WCST:CV4 total errors 46 (9.6) 51 (10.2) 49 (9.6) 1.8 .18
WCST:CV4 perseverative errors 4412H(0.83) 51 (12) 54 (12) 4.6 .02
WCST:CV4 nonperseverative errors 43 (7.4) 47 (9.3) 46 (7.6) 0.99 .38
WCST:CV4 time, s 313 (68)N(0.66),H(1.20) 267 (71) 246 (40) 3.3 .05
Digit span 11 (2.1) 11 (2.2) 11 (2.4) 0.1 .88
Letter fluencyb 12 (3.9) 13 (3.7) 14 (3.1) 2.5 .09
BRIEF 64 (13)N(0.96),H(1.20) 52 (12) 51 (9) 8.5 .001
CAD 50 (10) 44 (12) 47 (10) 1.0 .37
fMRI task correct, % 69 (12) 70 (16) 69 (17) 0.1 .92
fMRI task reaction time, ms 1370 (268) 1324 (215) 1371 (224) 0.3 .71

Abbreviations: BRIEF, Behavioral Rating Inventory of Executive Function; CAD, Clinical Assessment of Depression; fMRI, functional magnetic resonance imaging; WCST:CV4, Wisconsin Card Sorting Test Computer Version 4–Research Edition.

a

H Indicates significantly different from the healthy control group; N significantly different from the no-chemotherapy group. Effect size is shown in the superscript parentheses for significant pairwise comparisons.

b

Section of the verbal fluency subtest of the Delis-Kaplan Executive Function System.